Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Major Depressive Disorder (Part 2)”

14 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 14 results

Testing effectiveness (Phase 2)Study completedNCT06309277
What this trial is testing

A Clinical Study to Evaluate of Single and Multiple Oral Doses of GM-1020 in Patients With MDD

Who this might be right for
Major Depressive Disorder
Gilgamesh Pharmaceuticals 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT05434156
What this trial is testing

ELE-101 Safety & Tolerability Study in Healthy Participants and Patients With Depression

Who this might be right for
Healthy VolunteersMajor Depressive DisorderDepression
Eleusis Therapeutics 84
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07772531
What this trial is testing

Evaluate BMS-986511 in Adults With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Bristol-Myers Squibb 200
Testing effectiveness (Phase 2)Study completedNCT01413932
What this trial is testing

Pharmacokinetics - Pharmacodynamic Study of HT-2157 in Healthy Subjects and in Patients With Major Depressive Disorder

Who this might be right for
Healthy Volunteers (Part 1)Major Depressive Disorder (Part 2)
Dart NeuroScience, LLC 26
Not applicableEnded earlyNCT01804296
What this trial is testing

RTMS for Depressed Teens: A Sham-Controlled Trial, Part 2

Who this might be right for
Major Depressive Disorder
Paul E. Croarkin 4
Early research (Phase 1)Study completedNCT00559299
What this trial is testing

Patient Tolerability Study of GSK163090

Who this might be right for
Depressive Disorder, MajorMajor Depressive Disorder (MDD)
GlaxoSmithKline 20
Testing effectiveness (Phase 2)Study completedNCT03000530
What this trial is testing

Evaluate SAGE-217 in Participants With Moderate to Severe Major Depressive Disorder

Who this might be right for
Major Depression
Biogen 102
Testing effectiveness (Phase 2)Study completedNCT03692910
What this trial is testing

Evaluate SAGE-217 in Participants With Bipolar I/II Disorder With a Current Major Depressive Episode

Who this might be right for
Bipolar Disorder IBipolar Disorder IIMajor Depressive Episode
Biogen 35
Early research (Phase 1)Ended earlyNCT01359618
What this trial is testing

Determining Highest Dose Administration of TC-5214 and Evaluating Effect on the Electrical Activity in the Heart

Who this might be right for
Healthy Male
AstraZeneca 16
Testing effectiveness (Phase 2)Study completedNCT07101120
What this trial is testing

Evaluate Efficacy and Safety of KH607 Tablets in Adult Participents With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder (MDD)
Chengdu Kanghong Pharmaceutical Group Co., Ltd. 126
Testing effectiveness (Phase 2)Study completedNCT03726658
What this trial is testing

Zelquistinel in the Treatment of Adults With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Syndeio Biosciences, Inc 226
Large-scale testing (Phase 3)Looking for participantsNCT06559306
What this trial is testing

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

Who this might be right for
Depressive Disorder, Major
Janssen Research & Development, LLC 752
Testing effectiveness (Phase 2)Study completedNCT04669665
What this trial is testing

SLS-002 (Intranasal Racemic Ketamine) in Adults With Major Depressive Disorder at Imminent Risk of Suicide

Who this might be right for
Depressive Disorder, MajorSuicidal
Seelos Therapeutics, Inc. 164
Testing effectiveness (Phase 2)Study completedNCT04103892
What this trial is testing

CLE-100 (Oral Esketamine) in Addition to Standard Antidepressant Drug for Major Depressive Disorder - CLEO Study

Who this might be right for
Adjunctive Treatment of Major Depressive Disorder
Clexio Biosciences Ltd. 146